サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451546

小児用ワクチン市場レポート：タイプ、技術、用途、地域別、2024-2032

Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
小児用ワクチン市場レポート：タイプ、技術、用途、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の小児用ワクチン市場規模は2023年に370億米ドルに達しました。今後、IMARC Groupは、2024～2032年の成長率（CAGR）は7.26%で、2032年には703億米ドルに達すると予測しています。ワクチン接種プログラムの新興国市場の拡大、混合ワクチンへの注目の高まり、ワクチンの開発と流通を迅速に進めるための製薬会社とヘルスケア機関とのパートナーシップの高まりなどが、市場を牽引する主な要因のひとつです。

小児用ワクチンは、細菌やウイルスなどの特定の感染因子を認識して闘うよう免疫系を刺激する医療用製剤です。小児用ワクチンは、病原体の弱毒化または不活化形態、あるいは病原体の成分から構成され、免疫系に標的疾患に対する防御機構の発達を促します。麻疹、ポリオ、百日咳、肝炎、インフルエンザから身を守る。これらの予防接種は、使用が承認される前に、安全性を確保するために厳格な試験と評価を受けています。小児に重篤な合併症を引き起こしたり、死に至らしめたりする可能性のある病気の蔓延を防ぐのです。

現在、小児の間でポリオ、結核、マラリアなど、さまざまな感染症や生命を脅かす可能性のある病気の発生が増加していることが、市場の成長を促しています。このほか、予防可能な病気に対する子どもの予防接種を目的とした政府の取り組みが世界各地で活発化していることも、市場の成長に寄与しています。さらに、医療インフラが未発達な地域でのサプライチェーンを改善するため、ワクチンの保管や流通方法に関する技術的進歩が進んでいることも、市場の見通しを良好なものにしています。これとは別に、ワクチンの開発と流通を迅速に進めるための製薬会社とヘルスケア機関とのパートナーシップの高まりが、市場の成長を支えています。さらに、ヘルスケアサービス向上のために世界中でクリニックや病院の建設が増加していることも、市場の成長を後押ししています。

小児用ワクチン市場の動向と促進要因：

予防接種プログラムの増加

予防接種プログラムの実施が増加していることは、小児用ワクチン市場を著しく強化しています。政府機関や非政府組織が支援するこうした予防接種イニシアチブは、子どもたちの健康と福祉を守る上で極めて重要な役割を果たしています。より多くの子どもたちが様々な病気に対する予防接種を受けるようになり、小児用ワクチンの需要もそれに比例して増加しています。その上、疾病予防に重点を置いた予防接種プログラムは、子どもたちの間で対象となる疾病の発生率を減少させています。その結果、ヘルスケアシステムや家族の負担が軽減され、子どもとその介護者の生活の質が全体的に向上しています。さらに、予防接種の重要性に対する保護者やヘルスケア提供者の意識の高まりにより、ワクチン接種率が上昇しています。

混合ワクチンへの注目の高まり

混合ワクチンへの注目の高まりは、小児用ワクチン市場の積極的な発展に寄与しています。混合ワクチンは、1つの製剤で複数の疾患に対する予防を提供することで、予防接種への戦略的アプローチを提供します。このアプローチにより、ヘルスケアプロバイダー、介護者、小児が同様にワクチン接種プロセスを簡素化し、コンプライアンスと接種率の向上につながります。さらに、混合ワクチンは、ワクチン接種のためらいや接種漏れの可能性という課題にも対処します。子どもたちは1回の注射で複数の病気に対する予防を受けられるため、予防接種の負担感は大幅に軽減されます。このため、保護者は推奨される予防接種スケジュールを守るようになり、予防接種の完全接種率の向上に寄与しています。

新規ワクチンの開発増加

新規ワクチンの開発増加は、小児用ワクチン市場の成長を促進する上で極めて重要な役割を果たしています。小児の健康ニーズに特化した新規ワクチンの出現は、疾病予防の強化、公衆衛生の改善、市場機会の拡大に寄与しています。新規ワクチンの開発は、ワクチン技術と研究の進歩も反映しています。ゲノミクスやバイオインフォマティクスのような最先端の調査手法により、科学者はワクチン候補をより迅速かつ正確に特定できるようになった。このように発見ペースが加速することで、効能が高く、疫学的状況の変化に対応したワクチンが生み出されています。さらに、新規ワクチンの開発が活発化することで、公衆衛生機関、研究機関、ワクチン製造業者間の連携が活性化しています。このようなパートナーシップにより、新しいワクチンのタイムリーなイントロダクションが促進され、小児人口への効率的な配布が保証されています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 小児用ワクチンの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 多価
    • 市場動向
    • 市場予測
  • 一価
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • コンジュゲート
    • 市場動向
    • 市場予測
  • ライブアテニュエート
    • 市場動向
    • 市場予測
  • 不活化
    • 市場動向
    • 市場予測
  • サブユニット
    • 市場動向
    • 市場予測
  • トキソイド
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 感染症
    • 市場動向
    • 市場予測
  • がん
    • 市場動向
    • 市場予測
  • アレルギー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Bio-Med Private Limited
    • Daiichi Sankyo Company Limited
    • GSK plc
    • Indian Immunologicals Limited（National Dairy Development Board）
    • Merck & Co. Inc.
    • Mitsubishi Tanabe Pharma Corporation（Mitsubishi Chemical Holdings Corporation）
    • Panacea Biotec Limited
    • Pfizer Inc.
    • Sanofi S.A.
    • Sinovac Biotech Ltd.
図表

List of Figures

  • Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
  • Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
  • Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pediatric Vaccines Market: Competitive Structure
  • Table 7: Global: Pediatric Vaccines Market: Key Players
目次
Product Code: SR112024A6230

The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032. The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.

Pediatric vaccines are medical preparations that stimulate the immune system to recognize and fight specific infectious agents, such as bacteria or viruses. They comprise weakened or inactivated forms of the pathogens, or components of the pathogens, which prompt the immune system to develop a defense mechanism against the targeted disease. They provide protection from measles, polio, pertussis (whooping cough), hepatitis, and influenza. They undergo rigorous testing and evaluation to ensure their safety before being approved for use. They prevent the spread of diseases that can cause severe complications or death in children.

At present, the increasing occurrence of various infectious and potentially life-threatening diseases, such as polio, tuberculosis (TB), and malaria among children, is impelling the growth of the market. Besides this, rising government initiatives around the world aimed at immunizing children against preventable diseases are contributing to the growth of the market. In addition, the growing technological advancements in vaccine storage and distribution methods for improving the supply chain in regions where medical infrastructure may be less developed are offering a favorable market outlook. Apart from this, increasing partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are supporting the growth of the market. Additionally, the rising construction of clinics and hospitals around the world to improve healthcare services is bolstering the growth of the market.

Pediatric Vaccines Market Trends/Drivers:

Growing conduction of vaccination programs

The increasing implementation of vaccination programs is notably bolstering the pediatric vaccines market. These vaccination initiatives, supported by governmental and non-governmental organizations, play a pivotal role in safeguarding the health and well-being of children. As more children receive essential immunizations against various diseases, the demand for pediatric vaccines experiences a proportional rise. Besides this, vaccination programs, with their focus on disease prevention, are decreasing the incidence of targeted illnesses among children. This subsequently translates into a reduced burden on healthcare systems and families, thereby enhancing the overall quality of life for children and their caregivers. Furthermore, the growing awareness among parents and healthcare providers about the importance of immunizations is rising the vaccine uptake rates.

Increasing focus on combination vaccines

The heightened emphasis on combination vaccines is contributing to the positive evolution of the pediatric vaccines market. Combination vaccines offer a strategic approach to immunization by providing protection against multiple diseases in a single formulation. This approach simplifies the vaccination process for healthcare providers, caregivers, and children alike, resulting in improved compliance and vaccine coverage rates. Moreover, combination vaccines address the challenges of vaccine hesitancy and the possibility of missed doses. As children receive protection against multiple diseases with one injection, the perceived burden of vaccinations is significantly reduced. This encourages parents to adhere to recommended vaccination schedules and contributes to achieving higher rates of full immunization coverage.

Rising development of novel vaccines

The increasing development of novel vaccines is playing a pivotal role in driving positive growth within the pediatric vaccines market. The emergence of new vaccines tailored specifically for the health needs of children contributes to enhanced disease prevention, improved public health outcomes, and expanded market opportunities. The development of novel vaccines also reflects advancements in vaccine technology and research. Cutting-edge research methodologies, such as genomics and bioinformatics, enable scientists to identify potential vaccine candidates more rapidly and accurately. This accelerated pace of discovery is creating vaccines that are efficacious and align with the evolving epidemiological landscape. Furthermore, the rising development of novel vaccines is stimulating collaboration between public health organizations, research institutions, and vaccine manufacturers. These partnerships facilitate the timely introduction of new vaccines and ensure their efficient distribution to the pediatric population.

Pediatric Vaccines Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pediatric vaccines market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, technology, and application.

Breakup by Type:

Multivalent

Monovalent

Multivalent dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes multivalent and monovalent. According to the report, multivalent represented the largest segment.

Multivalent pediatric vaccines refer to immunization formulations that provide protection against multiple diseases through a single vaccine injection. These vaccines are designed to target two or more different disease-causing agents, such as viruses or bacteria, in a single formulation. Multivalent pediatric vaccines streamline the vaccination process by offering protection against multiple diseases with a single injection. This eliminates the need for multiple shots, reducing discomfort for children and simplifying the vaccination schedule for healthcare providers and caregivers. Multivalent pediatric vaccines optimize healthcare resources by combining multiple vaccines into a single formulation. This can result in cost savings for healthcare systems and reduce the logistical challenges associated with administering separate vaccines.

Breakup by Technology:

Conjugate

Live Attenuated

Inactivated

Subunit

Toxoid

Others

Conjugate holds the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes conjugate, live attenuated, inactivated, subunit, toxoid, and others. According to the report, conjugate accounted for the largest market share.

Conjugate vaccines are a type of immunization that enhances the immune response against certain bacteria that have a protective polysaccharide outer coating. These vaccines work by linking or conjugating the bacterial polysaccharides to a carrier protein, creating a complex that stimulates a stronger and more effective immune response, especially in young children whose immune systems might not respond well to polysaccharides alone. Conjugate vaccines not only protect vaccinated individuals but can also reduce the carriage of bacteria in the population. This indirectly limits the spread of bacteria among both vaccinated and unvaccinated individuals. Conjugate vaccines contribute to herd immunity, which is essential for the prevention of the spreading of various infectious diseases among unvaccinated individuals.

Breakup by Application:

Infectious Disease

Cancer

Allergy

Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes infectious disease, cancer, allergy, and others.

Pediatric vaccines play a crucial role in preventing infectious diseases among children. By providing immunity against harmful pathogens, vaccines contribute to the health and well-being of children and infants. These vaccines are carefully developed based on scientific examination and clinical trials to ensure their safety and effectiveness.

Pediatric vaccines for cancer aim to prevent certain types of cancers that primarily affect children. They target certain infections, such as human papillomavirus (HPV) and hepatitis B virus (HBV) and are known to increase the risk of developing cancer. Besides this, administering vaccines during childhood allows for early prevention of cancer-related infections. This early intervention aligns with a proactive health approach, reducing the risk of cancer development later in life.

Pediatric vaccines play a crucial role in preventing a range of allergies among children. By bolstering the response of the immune system, vaccines help mitigate the risk of developing allergies to common allergens like pollen, dust, and pet dander.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest pediatric vaccines market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region due to the rising investment in research operations for the development of various novel vaccines for the prevention of infectious and chronic diseases. Besides this, the increasing awareness among parents and caregivers about the importance of immunization is propelling the growth of the market. Apart from this, rising improvements in the healthcare infrastructure to provide quality treatment and other healthcare facilities to individuals are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the increasing occurrence of infectious diseases caused by various novel viruses. Besides this, rising initiatives taken by governing agencies and regulatory bodies to promote the significance of vaccination in children are bolstering the growth of the market.

Competitive Landscape:

Key market players are diligently focused on enhancing their business strategies by consistently investing in research operations to formulate innovative vaccines that cater to evolving healthcare needs. They are fostering collaborations with research institutions and regulatory bodies to ensure the safety and efficacy of their products. Leading companies are strengthening their supply chain management and distribution networks to ensure timely availability of vaccines. Furthermore, top industry players are actively engaging in educational initiatives to increase awareness about the importance of vaccination, fostering trust and credibility within the community. This concerted effort to innovate, collaborate, and educate showcases their commitment to advancing the field of pediatric vaccines and contributing to public health on a global scale.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Bio-Med Private Limited

Daiichi Sankyo Company Limited

GSK plc

Indian Immunologicals Limited (National Dairy Development Board)

Merck & Co. Inc.

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)

Panacea Biotec Limited

Pfizer Inc.

Sanofi S.A.

Sinovac Biotech Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global pediatric vaccines market in 2023?
  • 2. What is the expected growth rate of the global pediatric vaccines market during 2024-2032?
  • 3. What are the key factors driving the global pediatric vaccines market?
  • 4. What has been the impact of COVID-19 on the global pediatric vaccines market?
  • 5. What is the breakup of the global pediatric vaccines market based on the type?
  • 6. What is the breakup of the global pediatric vaccines market based on the technology?
  • 7. What are the key regions in the global pediatric vaccines market?
  • 8. Who are the key players/companies in the global pediatric vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pediatric Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multivalent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Monovalent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Conjugate
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Toxoid
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Allergy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Med Private Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Daiichi Sankyo Company Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 GSK plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Panacea Biotec Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinovac Biotech Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials